Announced
Completed
Financials
Sources
Tags
Biotechnology
France
Private
Friendly
Completed
biotechnology company
Venture Capital
Acquisition
Cross Border
Minority
Private Equity
Synopsis
Bpifrance, Kurma Partners, Angelini Pharma, Evotec, and Institut Pasteur led a $59m investment in Argobio, start-up studio dedicated to life sciences. “Building on our BRIDGE strategy and partnerships, we continue to be dedicated to making Evotec’s all-modality technology platforms available to validate and accelerate therapeutic concepts from toptier academic institutions globally. As an investor into Argobio, we are delighted to work with a group of distinguished partners and entrepreneurs to build companies committed to the maturation of first-in-class therapeutics towards drugs that which will change patients’ lives and cure diseases with some of the highest medical needs,” Werner Lanthaler, Evotec CEO.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.